Show simple item record

Celexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial

dc.contributor.authorArdicoglu, O
dc.contributor.authorSeyahi, E
dc.contributor.authorAkarirmak, U
dc.contributor.authorYazici, H
dc.contributor.authorOzdemir, O
dc.contributor.authorKirazli, Y
dc.contributor.authorOzbek, S
dc.contributor.authorOzerbil, O
dc.contributor.authorGur, A
dc.contributor.authorSepici, V
dc.contributor.authorUysal, FG
dc.contributor.authorErtenli, I
dc.contributor.authorInal, V
dc.contributor.authorKayhan, O
dc.contributor.authorKuru, O
dc.contributor.authorGilgil, E
dc.contributor.authorBingol, U
dc.contributor.authorAksoy, C
dc.contributor.authorErgin, S
dc.contributor.authorCetin, A
dc.contributor.authorTan, K
dc.contributor.authorAral, O
dc.date.accessioned2021-03-05T17:05:46Z
dc.date.available2021-03-05T17:05:46Z
dc.identifier.citationYazici H., Ozdemir O., Kirazli Y., Ozbek S., Ozerbil O., Gur A., Ardicoglu O., Seyahi E., Akarirmak U., Sepici V., et al., "Celexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial", Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.260
dc.identifier.othervv_1032021
dc.identifier.otherav_c3d764c6-a6be-48d4-bc28-5b02d58726a0
dc.identifier.urihttp://hdl.handle.net/20.500.12627/129923
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİmmünoloji ve Romatoloji
dc.titleCelexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial
dc.typeBildiri
dc.contributor.department, ,
dc.identifier.volume62
dc.contributor.firstauthorID128755


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record